Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents

PURPOSE: The purpose of this study was to evaluate overall survival after systemic therapy, largely chemotherapy, in patients with small cell or non-small cell lung cancer and brain metastases. After completion of systemic therapy, some patients received planned brain irradiation, while others were...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieder, Carsten, Aanes, Siv G., Haukland, Ellinor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508211/
https://www.ncbi.nlm.nih.gov/pubmed/35020043
http://dx.doi.org/10.1007/s00432-022-03919-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508211/
https://www.ncbi.nlm.nih.gov/pubmed/35020043
http://dx.doi.org/10.1007/s00432-022-03919-0

Ejemplares similares